Overview

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

Status:
Recruiting
Trial end date:
2023-03-30
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of SA58 nasal spray in close contact with COVID-19 people.
Phase:
N/A
Details
Lead Sponsor:
Sinovac Life Sciences Co., Ltd.
Collaborator:
Beijing Ditan Hospital